HEADER ANTIFREEZE PROTEIN 21-FEB-12 2LQ0 TITLE SOLUTION STRUCTURE OF DE NOVO DESIGNED ANTIFREEZE PEPTIDE 1M COMPND MOL_ID: 1; COMPND 2 MOLECULE: DE NOVO DESIGNED ANTIFREEZE PEPTIDE 1M; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS AFP, ANTIFREEZE PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.BHUNIA REVDAT 2 26-DEC-12 2LQ0 1 JRNL REVDAT 1 24-OCT-12 2LQ0 0 JRNL AUTH S.H.SHAH,R.K.KAR,A.A.ASMAWI,M.B.RAHMAN,A.M.MURAD,N.M.MAHADI, JRNL AUTH 2 M.BASRI,R.N.RAHMAN,A.B.SALLEH,S.CHATTERJEE,B.A.TEJO,A.BHUNIA JRNL TITL SOLUTION STRUCTURES, DYNAMICS, AND ICE GROWTH INHIBITORY JRNL TITL 2 ACTIVITY OF PEPTIDE FRAGMENTS DERIVED FROM AN ANTARCTIC JRNL TITL 3 YEAST PROTEIN JRNL REF PLOS ONE V. 7 49788 2012 JRNL REFN ESSN 1932-6203 JRNL PMID 23209600 JRNL DOI 10.1371/JOURNAL.PONE.0049788 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUNTERT, BRAUN AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-FEB-12. REMARK 100 THE RCSB ID CODE IS RCSB102688. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 0.8 MM PEPTIDE 1M-1, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18284 RELATED DB: BMRB REMARK 900 RELATED ID: 2LQ1 RELATED DB: PDB REMARK 900 RELATED ID: 2LQ2 RELATED DB: PDB DBREF 2LQ0 A 1 25 PDB 2LQ0 2LQ0 1 25 SEQRES 1 A 25 GLN ARG SER ASN PHE HIS PRO LEU ALA ALA SER PHE ILE SEQRES 2 A 25 VAL ARG CYS ALA PHE GLU HIS SER ARG ARG PHE THR HELIX 1 1 GLN A 1 ARG A 23 1 23 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 69 0 0 1 0 0 0 6 0 0 0 2 END